Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection

Therapeutic antibodies against flaviviruses often promote neutralization by targeting the envelope protein of the virion. However, this approach is hindered by a possible concern for antibody-dependent enhancement of infection and paradoxical worsening of disease.

Guardado en:
Detalles Bibliográficos
Autores principales: Alex W. Wessel, Michael P. Doyle, Taylor B. Engdahl, Jessica Rodriguez, James E. Crowe, Michael S. Diamond
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://doaj.org/article/452803504505489b8c84cd953cbd6230
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:452803504505489b8c84cd953cbd6230
record_format dspace
spelling oai:doaj.org-article:452803504505489b8c84cd953cbd62302021-11-03T21:52:35ZHuman Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection2150-751110.1128/mBio.02440-21https://doaj.org/article/452803504505489b8c84cd953cbd62302021-10-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.02440-21https://doaj.org/toc/2150-7511 Therapeutic antibodies against flaviviruses often promote neutralization by targeting the envelope protein of the virion. However, this approach is hindered by a possible concern for antibody-dependent enhancement of infection and paradoxical worsening of disease.Alex W. WesselMichael P. DoyleTaylor B. EngdahlJessica RodriguezJames E. CroweMichael S. DiamondAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 12, Iss 5 (2021)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Alex W. Wessel
Michael P. Doyle
Taylor B. Engdahl
Jessica Rodriguez
James E. Crowe
Michael S. Diamond
Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection
description Therapeutic antibodies against flaviviruses often promote neutralization by targeting the envelope protein of the virion. However, this approach is hindered by a possible concern for antibody-dependent enhancement of infection and paradoxical worsening of disease.
format article
author Alex W. Wessel
Michael P. Doyle
Taylor B. Engdahl
Jessica Rodriguez
James E. Crowe
Michael S. Diamond
author_facet Alex W. Wessel
Michael P. Doyle
Taylor B. Engdahl
Jessica Rodriguez
James E. Crowe
Michael S. Diamond
author_sort Alex W. Wessel
title Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection
title_short Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection
title_full Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection
title_fullStr Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection
title_full_unstemmed Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection
title_sort human monoclonal antibodies against ns1 protein protect against lethal west nile virus infection
publisher American Society for Microbiology
publishDate 2021
url https://doaj.org/article/452803504505489b8c84cd953cbd6230
work_keys_str_mv AT alexwwessel humanmonoclonalantibodiesagainstns1proteinprotectagainstlethalwestnilevirusinfection
AT michaelpdoyle humanmonoclonalantibodiesagainstns1proteinprotectagainstlethalwestnilevirusinfection
AT taylorbengdahl humanmonoclonalantibodiesagainstns1proteinprotectagainstlethalwestnilevirusinfection
AT jessicarodriguez humanmonoclonalantibodiesagainstns1proteinprotectagainstlethalwestnilevirusinfection
AT jamesecrowe humanmonoclonalantibodiesagainstns1proteinprotectagainstlethalwestnilevirusinfection
AT michaelsdiamond humanmonoclonalantibodiesagainstns1proteinprotectagainstlethalwestnilevirusinfection
_version_ 1718445391552184320